NO923509L - N-SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING THEM - Google Patents
N-SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING THEMInfo
- Publication number
- NO923509L NO923509L NO92923509A NO923509A NO923509L NO 923509 L NO923509 L NO 923509L NO 92923509 A NO92923509 A NO 92923509A NO 923509 A NO923509 A NO 923509A NO 923509 L NO923509 L NO 923509L
- Authority
- NO
- Norway
- Prior art keywords
- preparing
- substituted heterocyclic
- heterocyclic compounds
- mixtures containing
- pharmaceutical mixtures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9111161A FR2681067B1 (en) | 1991-09-10 | 1991-09-10 | N-SUBSTITUTED HETEROCYCLIC DERIVATIVES, THEIR PREPARATION, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. |
Publications (4)
Publication Number | Publication Date |
---|---|
NO923509D0 NO923509D0 (en) | 1992-09-09 |
NO923509L true NO923509L (en) | 1993-03-11 |
NO180678B NO180678B (en) | 1997-02-17 |
NO180678C NO180678C (en) | 1997-05-28 |
Family
ID=9416798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO923509A NO180678C (en) | 1991-09-10 | 1992-09-09 | N-substituted heterocyclic compounds and pharmaceutical preparation |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0532410A1 (en) |
JP (1) | JPH05213894A (en) |
KR (1) | KR930006008A (en) |
AU (1) | AU661017B2 (en) |
CA (1) | CA2077967A1 (en) |
CZ (1) | CZ275992A3 (en) |
FR (1) | FR2681067B1 (en) |
HU (1) | HUT63616A (en) |
IL (1) | IL103116A (en) |
LT (1) | LT3148B (en) |
LV (1) | LV10255B (en) |
MX (1) | MX9205155A (en) |
MY (1) | MY108089A (en) |
NO (1) | NO180678C (en) |
NZ (1) | NZ244258A (en) |
PL (1) | PL171524B1 (en) |
RU (1) | RU2107062C1 (en) |
TW (1) | TW218871B (en) |
ZA (1) | ZA926899B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3398379B2 (en) * | 1990-12-14 | 2003-04-21 | スミスクライン・ビーチャム・コーポレイション | Angiotensin II receptor blocking composition |
US5484939A (en) * | 1993-03-12 | 1996-01-16 | Lonza Ltd. | 2-substituted 5-chlorimidazoles |
US5721263A (en) * | 1993-06-07 | 1998-02-24 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for angiotensin II-mediated diseases |
HU218680B (en) | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Process for the preparation of 1,3-diaza-spiro(4,4)non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates |
HU218681B (en) * | 1997-07-25 | 2000-10-30 | Sanofi-Synthelabo | Process for the preparation of 1,3-diaza-spiro(4,4)non-1-en-4-one derivatives and 1-cyano-1-acylamino-cyclopentane intermediates |
US6638937B2 (en) | 1998-07-06 | 2003-10-28 | Bristol-Myers Squibb Co. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
SK18822000A3 (en) | 1998-07-06 | 2001-12-03 | Bristol-Myers Squibb Company | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
NZ541454A (en) | 2003-01-31 | 2008-04-30 | Daiichi Sankyo Co Ltd | Medicine for prevention of and treatment for arteriosclerosis and hypertension |
PL1750862T3 (en) | 2004-06-04 | 2011-06-30 | Teva Pharma | Pharmaceutical composition containing irbesartan |
JP4173909B1 (en) * | 2005-04-28 | 2008-10-29 | ファイザー・リミテッド | Amino acid derivatives |
EA020466B1 (en) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CN113388007A (en) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | Ultra-pure agonists of guanylate cyclase C, methods of making and using the same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH540271A (en) | 1970-05-29 | 1973-08-15 | Agripat Sa | Herbicidal triazines-2-substd-4-amino-6-(1'-cyclopropyl-1'-cyano - -alkyl-amino)-s-triazines |
US4017510A (en) | 1975-11-12 | 1977-04-12 | American Cyanamid Company | Imidazoisoindolediones and the use thereof as herbicidal agents |
DE3545597A1 (en) * | 1985-12-21 | 1987-07-02 | Celamerck Gmbh & Co Kg | NEW HERBICIDE EFFECTIVE IMIDAZOLINONES |
EP0303863A3 (en) * | 1987-08-17 | 1991-10-23 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds, intermediate compounds and methods of preparation thereof and use of said compounds and intermediate compounds as herbicidal agents |
US4880804A (en) * | 1988-01-07 | 1989-11-14 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking benzimidazoles |
CA2020073A1 (en) * | 1989-07-03 | 1991-01-04 | Eric E. Allen | Substituted quinazolinones as angiotensin ii antagonists |
DE69024556T2 (en) * | 1989-07-28 | 1996-10-17 | Merck & Co Inc | Substituted triazolinones, triazolinthiones and triazolinimines as angiotensin II antagonists |
IL99372A0 (en) * | 1990-09-10 | 1992-08-18 | Ciba Geigy Ag | Azacyclic compounds |
JP2004247578A (en) | 2003-02-14 | 2004-09-02 | Kawasaki Microelectronics Kk | Semiconductor device and its manufacturing method |
-
1991
- 1991-09-10 FR FR9111161A patent/FR2681067B1/en not_active Expired - Fee Related
-
1992
- 1992-08-26 TW TW081106738A patent/TW218871B/zh active
- 1992-09-04 LV LVP-92-109A patent/LV10255B/en unknown
- 1992-09-04 CZ CS922759A patent/CZ275992A3/en unknown
- 1992-09-04 MY MYPI92001566A patent/MY108089A/en unknown
- 1992-09-08 NZ NZ244258A patent/NZ244258A/en unknown
- 1992-09-08 LT LTIP119A patent/LT3148B/en not_active IP Right Cessation
- 1992-09-09 NO NO923509A patent/NO180678C/en unknown
- 1992-09-09 MX MX9205155A patent/MX9205155A/en unknown
- 1992-09-09 PL PL92295874A patent/PL171524B1/en unknown
- 1992-09-09 EP EP92402459A patent/EP0532410A1/en not_active Withdrawn
- 1992-09-09 IL IL103116A patent/IL103116A/en not_active IP Right Cessation
- 1992-09-09 HU HU9202889A patent/HUT63616A/en unknown
- 1992-09-09 KR KR1019920016618A patent/KR930006008A/en not_active Application Discontinuation
- 1992-09-09 RU SU5052773A patent/RU2107062C1/en active
- 1992-09-10 AU AU22868/92A patent/AU661017B2/en not_active Ceased
- 1992-09-10 CA CA002077967A patent/CA2077967A1/en not_active Abandoned
- 1992-09-10 ZA ZA926899A patent/ZA926899B/en unknown
- 1992-09-10 JP JP4242126A patent/JPH05213894A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP0532410A1 (en) | 1993-03-17 |
LV10255A (en) | 1994-10-20 |
NO180678B (en) | 1997-02-17 |
AU2286892A (en) | 1993-03-11 |
JPH05213894A (en) | 1993-08-24 |
NO923509D0 (en) | 1992-09-09 |
LT3148B (en) | 1995-01-31 |
TW218871B (en) | 1994-01-11 |
RU2107062C1 (en) | 1998-03-20 |
PL295874A1 (en) | 1993-04-19 |
AU661017B2 (en) | 1995-07-13 |
NZ244258A (en) | 1996-10-28 |
ZA926899B (en) | 1993-03-16 |
PL171524B1 (en) | 1997-05-30 |
CA2077967A1 (en) | 1993-03-11 |
FR2681067B1 (en) | 1993-12-17 |
IL103116A0 (en) | 1993-02-21 |
LV10255B (en) | 1995-04-20 |
CZ275992A3 (en) | 1993-03-17 |
HU9202889D0 (en) | 1992-11-30 |
IL103116A (en) | 1998-04-05 |
MY108089A (en) | 1996-08-15 |
MX9205155A (en) | 1993-03-01 |
FR2681067A1 (en) | 1993-03-12 |
KR930006008A (en) | 1993-04-20 |
LTIP119A (en) | 1994-07-15 |
HUT63616A (en) | 1993-09-28 |
NO180678C (en) | 1997-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO922940D0 (en) | FIVE-JOINT HETEROCYCLIC COMPOUNDS, PROCEDURES FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | |
DK0835246T3 (en) | Aromatic compounds and pharmaceutical preparations containing them | |
NO923509D0 (en) | N-SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING THEM | |
NO933248D0 (en) | Cyclic urea derivatives, drugs containing these compounds, and processes for their preparation | |
NO304374B1 (en) | 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, and pharmaceutical compositions containing them | |
NO924027D0 (en) | Heterobia Age Derivatives, Drugs Containing These Compounds, and Procedures for Their Preparation | |
NO932120D0 (en) | BIFENYL DERIVATIVES, PHARMACEUTICALS CONTAINING THESE, AND PROCEDURE FOR THEIR PREPARATION | |
DK605989A (en) | PROPENONOXYMETHERS AND PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL AGENTS CONTAINING THEM | |
DK286190A (en) | GLYCOSAMINOGLYCAN SALTS, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THEM | |
DK0732328T3 (en) | Heterocyclic, aromatic compounds, pharmaceutical and cosmetic compositions containing them, and uses | |
DK162491D0 (en) | Heterocyclic compounds, their preparation and pharmaceutical preparations containing the compounds | |
NO930796D0 (en) | GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE | |
NO166937C (en) | AROMATIC NAPULATE DERIVATIVES FOR COSMETIC APPLICATION AND COSMETIC MIXTURES CONTAINING THEM. | |
DK269289A (en) | CYCLOPENTAND DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
DK425384A (en) | ACYLINDOL DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
DK187989D0 (en) | SUBSTITUTED PROPANAMINES, PROCEDURES FOR THE PREPARATION OF THEM, AND PHARMACEUTICALS CONTAINING SUCH COMPOUNDS | |
NO933558D0 (en) | BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION | |
DK597184D0 (en) | SUBSTITUTED SPIRO-PYRIDINE DERIVATIVES, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCEDURE FOR PREPARING SUCH COMPOUNDS | |
NO305959B1 (en) | Thiosubstituted cyclic phosphonate compounds, uses thereof, and pharmaceutical preparations containing such compounds | |
NO923720D0 (en) | TIENOCYCLOPENTANONOXIMERS, PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING THEM | |
NO305699B1 (en) | New piperazine derivatives and pharmaceutical preparations containing them | |
NO942181D0 (en) | New, substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and processes for their preparation | |
DK300989A (en) | ALANINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
DK0618204T3 (en) | Heterocyclic compound and a cardiotonic containing this as an active ingredient | |
NO931420L (en) | NEW ARYLPIPERIDINE DERIVATIVE, PROCEDURE FOR PREPARING THEREOF AND PHARMACEUTICAL MIXTURES CONTAINING IT |